Summary of New Laws Impacting the Compassionate Use Program
HB 1535 Effective September 1, 2021
Caption: Relating to the medical use of low-THC cannabis by patients with certain medical conditions and the establishment of compassionate-use institutional review boards to evaluate and approve proposed research programs to study the medical use of low-THC cannabis in the treatment of certain patients.
- Expands the medical conditions for which low-THC cannabis may be prescribed to include non-terminal cancer, post-traumatic stress disorder, and those medical conditions designated by the Health and Human Services Commission as authorizing treatment with low-THC cannabis as part of an approved research program.
- Increases maximum THC level of low-THC cannabis to 1% by weight.
- Establishes compassionate-use institutional review boards to evaluate and approve proposed research programs to study the medical use of low-THC cannabis.